Senzime Expands TetraGraph's Clinical Use Beyond Surgery Into Brain Stimulation Therapy

UPPSALA, SE / ACCESS Newswire / November 5, 2026 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF), a global leader in precision-based patient monitoring, today announced the expanded clinical use of its TetraGraph system in electroconvulsive therapy …